ARNAUD AB BOURDIN
Impact in
- Physiology top 0.1%
- Asthma and respiratory diseases
- Obstructive Sleep Apnea Research
- Pulmonary and Respiratory Medicine top 0.5%
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Vasculitis and related conditions
Papers in
- Physiology 225
- Asthma and respiratory diseases 201
- Obstructive Sleep Apnea Research 20
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 67
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 22
- Pulmonary Hypertension Research and Treatments 21
- Vasculitis and related conditions 7
- Co-authors
- Pascal Chanez (78 shared papers)Isabelle Vachier (80 shared papers)Sandhia S. Ponnarambil (4 shared papers)Nicolas Molinari (72 shared papers)Andrew N Menzies-Gow (16 shared papers)Marc J.C. Humbert (18 shared papers)Njira Lucia Lugogo (8 shared papers)Parameswaran K. Nair (5 shared papers)
- Journals
- European Respiratory Journal (40 papers)ERJ Open Research (21 papers)Journal of Allergy and Clinical Immunology (17 papers)The Journal of Allergy and Clinical Immunology In Practice (17 papers)American Journal of Respiratory and Critical Care Medicine (16 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
ARNAUD AB BOURDIN
372 papers receiving 12.7k citations
ARNAUD AB BOURDIN's Hit Papers
Peers
Comparison fields: 5 of 150
- Physiology 6.5k
- Pulmonary and Respiratory Medicine 3.9k
- Otorhinolaryngology 314
- Immunology and Allergy 248
- Family Practice 56
Countries citing papers authored by ARNAUD AB BOURDIN
This map shows the geographic impact of ARNAUD AB BOURDIN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ARNAUD AB BOURDIN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ARNAUD AB BOURDIN more than expected).
Fields of papers citing papers by ARNAUD AB BOURDIN
This network shows the impact of papers produced by ARNAUD AB BOURDIN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ARNAUD AB BOURDIN. The network helps show where ARNAUD AB BOURDIN may publish in the future.
Co-authors
The 25 scholars most cited alongside ARNAUD AB BOURDIN, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 412 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma Hit paper breakdown → | 2017 | 860 |
| 2 | Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma Hit paper breakdown → | 2021 | 779 |
| 3 | Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Hit paper breakdown → | 2017 | 547 |
| 4 | Pulmonary Arterial Hypertension in Patients Treated by Dasatinib Hit paper breakdown → | 2012 | 521 |
| 5 | Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management Hit paper breakdown → | 2019 | 275 |
| 6 | 2018 | 256 | |
| 7 | 2018 | 253 | |
| 8 | Eosinophilic and Noneosinophilic Asthma Hit paper breakdown → | 2021 | 218 |
| 9 | Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study Hit paper breakdown → | 2021 | 184 |
| 10 | 2016 | 167 | |
| 11 | European Respiratory Society guidelines for the diagnosis of asthma in adults Hit paper breakdown → | 2022 | 164 |
| 12 | 2021 | 156 | |
| 13 | 2005 | 153 | |
| 14 | 2021 | 153 | |
| 15 | 2021 | 153 | |
| 16 | 2014 | 152 | |
| 17 | 2020 | 150 | |
| 18 | 2019 | 142 | |
| 19 | 2004 | 129 | |
| 20 | 2016 | 124 |
About ARNAUD AB BOURDIN
ARNAUD AB BOURDIN is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health, having authored 412 papers that have together received 13.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (201 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Pulmonary Hypertension Research and Treatments (21 papers), Obstructive Sleep Apnea Research (20 papers), Pluripotent Stem Cells Research (8 papers), Vasculitis and related conditions (7 papers) and Tuberculosis Research and Epidemiology (7 papers). The work is most often cited by research in Physiology (6.5k citations), Pulmonary and Respiratory Medicine (3.9k citations), Otorhinolaryngology (314 citations), Immunology and Allergy (248 citations) and Family Practice (56 citations). ARNAUD AB BOURDIN has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Pascal Chanez, Isabelle Vachier, Sandhia S. Ponnarambil, Nicolas Molinari, Andrew N Menzies-Gow, Marc J.C. Humbert, Njira Lucia Lugogo, Parameswaran K. Nair, Peter N. Barker and Philippe Godard. Their work appears in journals such as European Respiratory Journal, ERJ Open Research, Journal of Allergy and Clinical Immunology, The Journal of Allergy and Clinical Immunology In Practice and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.